Olympic Ophthalmics
Issaquah
About Olympic Ophthalmics
Olympic Ophthalmics is a medical device company developing novel treatments for dry eye disease. The company’s focus is to develop devices to treat the signs and symptoms of Dry Eye Disease (DED). It works by stimulating the trigeminal parasympathetic pathway to activate the glands responsible for tear film production. Olympic Ophthalmics was founded in 2017 by Michael Gertner and is based in Issaquah, Washington.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2018)
- Website: olympicophthalmics.com
Industries & Categories
Biotechnology, Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/olympic-ophthalmics-2845440 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.